Tango Therapeutics
TNGX
NASDAQ
IPO2021
about TNGX
Tango Therapeutics is a biopharmaceutical company dedicated to developing cutting-edge cancer immunotherapies through its proprietary platform, which identifies and targets unique tumor antigens to enhance treatment effectiveness.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $12.20 | $16.97 | $11.80 | $1.7B | 17.99M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.14 | n/a | 37.23 | 26.15% | 29.52% | 0% |